Literature DB >> 32852450

Prevalence of ocular surface disease symptoms in peri- and postmenopausal women.

Pascual Garcia-Alfaro1, Luciana Bergamaschi, Celia Marcos, Sandra Garcia, Ignacio Rodríguez.   

Abstract

OBJECTIVE: The objective of the study was to determine the prevalence of ocular surface disease (OSD) symptoms and the possible existence of differences between peri- and postmenopausal women, based on the result of the Ocular Surface Disease Index (OSDI).
METHODS: A transversal observational study based on the results of an e-mail survey between October 2018 and January 2019 involving 1,947 women. The study was performed on a group of peri- and postmenopausal women aged between 45 and 79 years. The personal data in the survey included age, menopause status, age at menopause, prediagnosis of dry eye, undergoing dry eye treatment, and the OSDI questionnaire. Student's t test and Chi squared test were used to compare means or percentages between results on the survey and peri- and postmenopausal women. Finally, a univariate logistic regression was carried out to estimate the prevalence of OSD. The OSDI score is assessed on a scale of 0 to 100.
RESULTS: The mean age of the entire sample was 54.2 ± 6.8 years, with a mean age at menopause of 49.45 ± 4.02 years. The mean OSDI score was 29.2 ± 19.4, considered as moderate dry eye. The global prevalence of OSD symptoms was 64% (1,247/1,947), which increased significantly in postmenopausal women, being 66.8% (820/1,228) (P = 0.001). The probability of OSD symptoms prevalence increases with age (odds ratio: 1.02; 95% CI [1.01-1.03]). The greater the age at menopause, the lower the probability of OSD symptoms prevalence (odds ratio: 0.96 95% CI [0.93-0.99]).
CONCLUSIONS: Sixty-four percent of the pre- and postmenopausal women studied had OSD symptoms. There was a correlation between OSD symptoms and age, postmenopause, and earlier age at menopause, which was associated with an increased prevalence. : Video Summary:http://links.lww.com/MENO/A603.

Entities:  

Mesh:

Year:  2020        PMID: 32852450     DOI: 10.1097/GME.0000000000001565

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  2 in total

1.  Dry eye, its clinical subtypes and associated factors in healthy pregnancy: A cross-sectional study.

Authors:  Kofi Asiedu; Samuel Kyei; Madison Adanusa; Richard Kobina Dadzie Ephraim; Stephen Animful; Stephen Karim Ali-Baya; Belinda Akorsah; Mabel Antwiwaa Sekyere
Journal:  PLoS One       Date:  2021-10-07       Impact factor: 3.240

2.  Efficacy of hyaluronic acid 0.3%, cyanocobalamin, electrolytes, and P-Plus in menopause patients with moderate dry eye disease.

Authors:  Concepción De-Hita-Cantalejo; María Carmen Sánchez-González; Carmen Silva-Viguera; Marta C García-Romera; Ricardo Feria-Mantero; José-María Sánchez-González
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-25       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.